Health Care: Drugs

Supernus Pharmaceuticals Inc (SUPN: NASDAQ)

$8.96 n/a | n/a%
08/19/14 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 8.96
52 Week High 11.47
52 Week Low 5.84
Avg. Daily Vol. (Mil) 0.46
Beta (3 year) 1.54
Share Related Items
Mkt Cap (Mil) 384.58
Shares Out (Mil) 42.92
Float (Mil) 25.28
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 2.60
Current Ratio 2.90
LT Debt/ Equity 0.98
Total Debt / Equity 0.98
Valuation Ratios
Price Earnings n.a.
Price/Sales 18.35
Price/Book 13.26
Price/Cash Flow -4.50
Per Share Data
Earnings -2.68
Sales 0.49
Book Value 0.68
Cash Flow -1.98
Business Summary
Supernus Pharmaceuticals Inc., is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system, or CNS, diseases.
General Information
1550 East Gude Drive
Rockville, MD 20850
www.supernus.com
Industry : Drugs
Sector: Health Care
Employees: 235
CEO: Jack Khattar
Short Interest
Current Month (Mil) 4.35
Previous Month (Mil) 3.76
Short Interest Ratio (Days) 10.10
Management Effectiveness
Return on Equity n.a.
Return on Assets -91.70
Return on Investments -155.80
Profitability
Gross Margin 92.40
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with SUPN

Latest SUPN Headlines from TheStreet

More Financial News for SUPN

Press Releases for SUPN

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter